The effect of 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase gene overexpression in the kynurenine pathway on the expression levels of indoleamine 2,3-dioxygenase 1 and interferon-γ in inflammatory conditions: an in vitro study
- 14 November 2021
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 49 (2) , 1103-1111
Abstract
Background The kynurenine pathway (KP) can be involved in the pathogenesis of neurodegenerative diseases and excessive neurotoxic metabolite production. This study aimed to evaluate the effects of overexpression of murine 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (Acmsd) gene in inflammatory conditions in RAW 264.7 cell line to present more information about the effect of this gene on inflammatory conditions and the KP cycle. Methods and results The coding sequence of the Acmsd gene was cloned into pCMV6-AC-IRES-GFP expression vector with a green fluorescent protein (GFP) marker. To simulate inflammatory conditions, RAW 264.7 macrophage cells were stimulated by Lipopolysaccharide (LPS) 24 h before transfection, and transfected by Polyethyleneimine (PEI) with constructed plasmids expressing the Acmsd gene. The effect of Acmsd gene expression level on murine Interferon-gamma (Ifn-γ) and murine Indoleamine 2,3-dioxygenase 1 (Ido1) gene expression level was investigated by Real-Time PCR. According to the results of this study, good transfection efficiency was observed 72 h after transfection, and Acmsd expression level increased 29-fold (P < 0.001) in transfected LPS-stimulated cells compared to the control group (LPS-stimulated cells that were not transfected). Additionally, increased Acmsd expression level significantly down-regulated Ifn-γ (P < 0.001) and Ido1 (P < 0.01) expression level in transfected LPS-stimulated cells compared to LPS-stimulated cells. Conclusions Acmsd gene overexpression in inflammatory conditions can reduce the expression levels of the Ido1 gene, and its regulator, Ifn-γ. Consequently, it may be considered as a novel regulatory factor in the KP balance.Keywords
Funding Information
- Shiraz University of Medical Sciences (97-16749)
This publication has 37 references indexed in Scilit:
- Kynurenine pathway metabolites and suicidalityNeuropharmacology, 2017
- The kynurenine pathway and neurodegenerative diseaseSeminars in Cell & Developmental Biology, 2015
- Involvement of the Kynurenine Pathway in Human Glioma PathophysiologyPLOS ONE, 2014
- Human α‐amino‐β‐carboxymuconate‐ε‐semialdehyde decarboxylase (ACMSD): A structural and mechanistic unveilingProteins: Structure, Function, and Bioinformatics, 2014
- Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease BrainPLOS ONE, 2013
- Characterization of the Kynurenine Pathway and Quinolinic Acid Production in Macaque MacrophagesInternational Journal of Tryptophan Research, 2013
- Kynurenines in the mammalian brain: when physiology meets pathologyNature Reviews Neuroscience, 2012
- Characterization of the Kynurenine Pathway in Human NeuronsThe Journal of Neuroscience, 2007
- Tissue expression and biochemical characterization of human 2‐amino 3‐carboxymuconate 6‐semialdehyde decarboxylase, a key enzyme in tryptophan catabolismThe FEBS Journal, 2007
- Evidence for Increased de Novo Synthesis of NAD in Immune-Activated RAW264.7 Macrophages: A Self-Protective Mechanism?Archives of Biochemistry and Biophysics, 1999